WO2008020597A1 - Procédé de production d'un intermédiaire pour la production de 1-méthylcarbapenem - Google Patents
Procédé de production d'un intermédiaire pour la production de 1-méthylcarbapenem Download PDFInfo
- Publication number
- WO2008020597A1 WO2008020597A1 PCT/JP2007/065896 JP2007065896W WO2008020597A1 WO 2008020597 A1 WO2008020597 A1 WO 2008020597A1 JP 2007065896 W JP2007065896 W JP 2007065896W WO 2008020597 A1 WO2008020597 A1 WO 2008020597A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- compound
- formula
- hydrogen atom
- general formula
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 53
- YKMONJZIUAOVEM-GDVGLLTNSA-N (5S)-4-methyl-1-azabicyclo[3.2.0]hept-2-en-7-one Chemical compound CC1C=CN2[C@H]1CC2=O YKMONJZIUAOVEM-GDVGLLTNSA-N 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 claims abstract description 125
- -1 malonic acid ester Chemical class 0.000 claims abstract description 106
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims abstract description 33
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims abstract description 29
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 49
- 238000006243 chemical reaction Methods 0.000 claims description 47
- 238000000034 method Methods 0.000 claims description 41
- 125000001424 substituent group Chemical group 0.000 claims description 36
- 125000006239 protecting group Chemical group 0.000 claims description 30
- 239000000126 substance Substances 0.000 claims description 29
- 239000002585 base Substances 0.000 claims description 19
- 229910052757 nitrogen Inorganic materials 0.000 claims description 18
- 125000000217 alkyl group Chemical group 0.000 claims description 17
- 125000003277 amino group Chemical group 0.000 claims description 16
- 125000003118 aryl group Chemical group 0.000 claims description 16
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 15
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 14
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims description 12
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 9
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 claims description 8
- 229910052726 zirconium Inorganic materials 0.000 claims description 8
- 150000002681 magnesium compounds Chemical class 0.000 claims description 7
- 238000005406 washing Methods 0.000 claims description 6
- 150000003755 zirconium compounds Chemical class 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims 1
- 239000007795 chemical reaction product Substances 0.000 claims 1
- 239000000543 intermediate Substances 0.000 abstract description 17
- 238000006193 diazotization reaction Methods 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 48
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 30
- 150000002148 esters Chemical class 0.000 description 30
- 238000004128 high performance liquid chromatography Methods 0.000 description 29
- 239000000243 solution Substances 0.000 description 25
- 239000002904 solvent Substances 0.000 description 25
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 24
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 24
- 239000000843 powder Substances 0.000 description 24
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical class Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 19
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 19
- 239000011541 reaction mixture Substances 0.000 description 19
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 18
- 238000005481 NMR spectroscopy Methods 0.000 description 17
- OKKLBZGYMORYHE-UHFFFAOYSA-N 4-methyl-n-[2-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC1=CC=CC=C1C(F)(F)F OKKLBZGYMORYHE-UHFFFAOYSA-N 0.000 description 16
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 16
- 239000000203 mixture Substances 0.000 description 16
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- LMYRWZFENFIFIT-UHFFFAOYSA-N toluene-4-sulfonamide Chemical compound CC1=CC=C(S(N)(=O)=O)C=C1 LMYRWZFENFIFIT-UHFFFAOYSA-N 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000003960 organic solvent Substances 0.000 description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 12
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 12
- XHWNEBDUPVMPKI-UHFFFAOYSA-N oxazetidine Chemical compound C1CON1 XHWNEBDUPVMPKI-UHFFFAOYSA-N 0.000 description 12
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 12
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- 239000007864 aqueous solution Substances 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 9
- 239000012044 organic layer Substances 0.000 description 9
- BWZVCCNYKMEVEX-UHFFFAOYSA-N 2,4,6-Trimethylpyridine Chemical compound CC1=CC(C)=NC(C)=C1 BWZVCCNYKMEVEX-UHFFFAOYSA-N 0.000 description 8
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2,5-dimethylpyridine Chemical compound CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 8
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 8
- ITQTTZVARXURQS-UHFFFAOYSA-N 3-methylpyridine Chemical compound CC1=CC=CN=C1 ITQTTZVARXURQS-UHFFFAOYSA-N 0.000 description 8
- FKNQCJSGGFJEIZ-UHFFFAOYSA-N 4-methylpyridine Chemical compound CC1=CC=NC=C1 FKNQCJSGGFJEIZ-UHFFFAOYSA-N 0.000 description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 8
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 7
- 125000005843 halogen group Chemical group 0.000 description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 125000003944 tolyl group Chemical group 0.000 description 7
- HPYNZHMRTTWQTB-UHFFFAOYSA-N 2,3-dimethylpyridine Chemical compound CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 6
- JYYNAJVZFGKDEQ-UHFFFAOYSA-N 2,4-Dimethylpyridine Chemical compound CC1=CC=NC(C)=C1 JYYNAJVZFGKDEQ-UHFFFAOYSA-N 0.000 description 6
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 6
- NURQLCJSMXZBPC-UHFFFAOYSA-N 3,4-dimethylpyridine Chemical compound CC1=CC=NC=C1C NURQLCJSMXZBPC-UHFFFAOYSA-N 0.000 description 6
- HWWYDZCSSYKIAD-UHFFFAOYSA-N 3,5-dimethylpyridine Chemical compound CC1=CN=CC(C)=C1 HWWYDZCSSYKIAD-UHFFFAOYSA-N 0.000 description 6
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical class CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 6
- MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical class O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 description 6
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 6
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 6
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 6
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methylaniline Chemical compound CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 239000012267 brine Substances 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 229940125898 compound 5 Drugs 0.000 description 5
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 5
- 229910001873 dinitrogen Inorganic materials 0.000 description 5
- 229910001629 magnesium chloride Inorganic materials 0.000 description 5
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 5
- 125000001624 naphthyl group Chemical group 0.000 description 5
- 125000004076 pyridyl group Chemical group 0.000 description 5
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 5
- AUHZEENZYGFFBQ-UHFFFAOYSA-N 1,3,5-Me3C6H3 Natural products CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 4
- ZOQOPXVJANRGJZ-UHFFFAOYSA-N 2-(trifluoromethyl)phenol Chemical compound OC1=CC=CC=C1C(F)(F)F ZOQOPXVJANRGJZ-UHFFFAOYSA-N 0.000 description 4
- YCMLQMDWSXFTIF-UHFFFAOYSA-N 2-methylbenzenesulfonimidic acid Chemical compound CC1=CC=CC=C1S(N)(=O)=O YCMLQMDWSXFTIF-UHFFFAOYSA-N 0.000 description 4
- VLVCWODDMDGANW-UHFFFAOYSA-N 4-methyl-n-phenylbenzenesulfonamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC1=CC=CC=C1 VLVCWODDMDGANW-UHFFFAOYSA-N 0.000 description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- 239000004215 Carbon black (E152) Substances 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 4
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 4
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- 229940126214 compound 3 Drugs 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 150000002430 hydrocarbons Chemical class 0.000 description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 4
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- DUNKXUFBGCUVQW-UHFFFAOYSA-J zirconium tetrachloride Chemical compound Cl[Zr](Cl)(Cl)Cl DUNKXUFBGCUVQW-UHFFFAOYSA-J 0.000 description 4
- ZCRVPHKAQIHANY-UHFFFAOYSA-N (ne)-n-diazo-2-dodecylbenzenesulfonamide Chemical compound CCCCCCCCCCCCC1=CC=CC=C1S(=O)(=O)N=[N+]=[N-] ZCRVPHKAQIHANY-UHFFFAOYSA-N 0.000 description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 3
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- IYXGSMUGOJNHAZ-UHFFFAOYSA-N Ethyl malonate Chemical compound CCOC(=O)CC(=O)OCC IYXGSMUGOJNHAZ-UHFFFAOYSA-N 0.000 description 3
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 125000001309 chloro group Chemical group Cl* 0.000 description 3
- 229940125773 compound 10 Drugs 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 125000001153 fluoro group Chemical group F* 0.000 description 3
- 238000007429 general method Methods 0.000 description 3
- 239000012442 inert solvent Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical group CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 3
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 3
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 3
- SKTCDJAMAYNROS-UHFFFAOYSA-N methoxycyclopentane Chemical compound COC1CCCC1 SKTCDJAMAYNROS-UHFFFAOYSA-N 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000012452 mother liquor Substances 0.000 description 3
- XTAZYLNFDRKIHJ-UHFFFAOYSA-N n,n-dioctyloctan-1-amine Chemical compound CCCCCCCCN(CCCCCCCC)CCCCCCCC XTAZYLNFDRKIHJ-UHFFFAOYSA-N 0.000 description 3
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- 125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- GJUIRYXOKRJRFF-ZCFIWIBFSA-N (5R)-2-methyl-1-azabicyclo[3.2.0]hept-2-en-7-one Chemical compound CC1=CC[C@H]2N1C(C2)=O GJUIRYXOKRJRFF-ZCFIWIBFSA-N 0.000 description 2
- AVFZOVWCLRSYKC-UHFFFAOYSA-N 1-methylpyrrolidine Chemical compound CN1CCCC1 AVFZOVWCLRSYKC-UHFFFAOYSA-N 0.000 description 2
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 2
- IXQGCWUGDFDQMF-UHFFFAOYSA-N 2-Ethylphenol Chemical compound CCC1=CC=CC=C1O IXQGCWUGDFDQMF-UHFFFAOYSA-N 0.000 description 2
- FTACTAWTKDTQSA-UHFFFAOYSA-N 2-methoxy-2,3,3-trimethylbutane Chemical group COC(C)(C)C(C)(C)C FTACTAWTKDTQSA-UHFFFAOYSA-N 0.000 description 2
- TUAMRELNJMMDMT-UHFFFAOYSA-N 3,5-xylenol Chemical compound CC1=CC(C)=CC(O)=C1 TUAMRELNJMMDMT-UHFFFAOYSA-N 0.000 description 2
- DDFHBQSCUXNBSA-UHFFFAOYSA-N 5-(5-carboxythiophen-2-yl)thiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)S1 DDFHBQSCUXNBSA-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 229910015900 BF3 Inorganic materials 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical class CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- AHVYPIQETPWLSZ-UHFFFAOYSA-N N-methyl-pyrrolidine Natural products CN1CC=CC1 AHVYPIQETPWLSZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical class OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 125000004799 bromophenyl group Chemical group 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Chemical compound [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 125000000068 chlorophenyl group Chemical group 0.000 description 2
- 229940125782 compound 2 Drugs 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 125000004802 cyanophenyl group Chemical group 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 125000004663 dialkyl amino group Chemical group 0.000 description 2
- JQVDAXLFBXTEQA-UHFFFAOYSA-N dibutylamine Chemical compound CCCCNCCCC JQVDAXLFBXTEQA-UHFFFAOYSA-N 0.000 description 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 239000004210 ether based solvent Substances 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- 125000001207 fluorophenyl group Chemical group 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- PQXKHYXIUOZZFA-UHFFFAOYSA-M lithium fluoride Chemical compound [Li+].[F-] PQXKHYXIUOZZFA-UHFFFAOYSA-M 0.000 description 2
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 description 2
- OTCKOJUMXQWKQG-UHFFFAOYSA-L magnesium bromide Chemical compound [Mg+2].[Br-].[Br-] OTCKOJUMXQWKQG-UHFFFAOYSA-L 0.000 description 2
- 229910001623 magnesium bromide Inorganic materials 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 2
- 125000006501 nitrophenyl group Chemical group 0.000 description 2
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 235000011181 potassium carbonates Nutrition 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 150000003456 sulfonamides Chemical class 0.000 description 2
- 150000003458 sulfonic acid derivatives Chemical class 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 2
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 2
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical class C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- FTTATHOUSOIFOQ-UHFFFAOYSA-N 1,2,3,4,6,7,8,8a-octahydropyrrolo[1,2-a]pyrazine Chemical compound C1NCCN2CCCC21 FTTATHOUSOIFOQ-UHFFFAOYSA-N 0.000 description 1
- QVCUKHQDEZNNOC-UHFFFAOYSA-N 1,2-diazabicyclo[2.2.2]octane Chemical compound C1CC2CCN1NC2 QVCUKHQDEZNNOC-UHFFFAOYSA-N 0.000 description 1
- KPZGRMZPZLOPBS-UHFFFAOYSA-N 1,3-dichloro-2,2-bis(chloromethyl)propane Chemical compound ClCC(CCl)(CCl)CCl KPZGRMZPZLOPBS-UHFFFAOYSA-N 0.000 description 1
- XNGWKILEDDFNCT-SECBINFHSA-N 1-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]azetidin-2-one Chemical compound CC(C)(C)[Si](C)(C)O[C@H](C)N1CCC1=O XNGWKILEDDFNCT-SECBINFHSA-N 0.000 description 1
- HYFLWBNQFMXCPA-UHFFFAOYSA-N 1-ethyl-2-methylbenzene Chemical class CCC1=CC=CC=C1C HYFLWBNQFMXCPA-UHFFFAOYSA-N 0.000 description 1
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- MFGOFGRYDNHJTA-UHFFFAOYSA-N 2-amino-1-(2-fluorophenyl)ethanol Chemical compound NCC(O)C1=CC=CC=C1F MFGOFGRYDNHJTA-UHFFFAOYSA-N 0.000 description 1
- KSUUDXKPIJEMBT-UHFFFAOYSA-N 2-diazo-3-oxopentanoic acid Chemical compound [N+](=[N-])=C(C(=O)O)C(CC)=O KSUUDXKPIJEMBT-UHFFFAOYSA-N 0.000 description 1
- MOEFFSWKSMRFRQ-UHFFFAOYSA-N 2-ethoxyphenol Chemical compound CCOC1=CC=CC=C1O MOEFFSWKSMRFRQ-UHFFFAOYSA-N 0.000 description 1
- XDZTVBLUGCFKFW-VEDVMXKPSA-N 3-[(1r)-1-[tert-butyl(dimethyl)silyl]oxyethyl]azetidin-2-one Chemical compound CC(C)(C)[Si](C)(C)O[C@H](C)C1CNC1=O XDZTVBLUGCFKFW-VEDVMXKPSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical class COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- RVDLHGSZWAELAU-UHFFFAOYSA-N 5-tert-butylthiophene-2-carbonyl chloride Chemical compound CC(C)(C)C1=CC=C(C(Cl)=O)S1 RVDLHGSZWAELAU-UHFFFAOYSA-N 0.000 description 1
- RIGFMUNSTCPGNP-UHFFFAOYSA-N 77359-11-6 Chemical compound OC(=O)CC(=O)OCC1=CC=C([N+]([O-])=O)C=C1 RIGFMUNSTCPGNP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 238000010485 C−C bond formation reaction Methods 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- IJEIYEJUYJRUSB-UHFFFAOYSA-N N-phenylmethanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=CC=C1.CS(=O)(=O)NC1=CC=CC=C1 IJEIYEJUYJRUSB-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- YSVZGWAJIHWNQK-UHFFFAOYSA-N [3-(hydroxymethyl)-2-bicyclo[2.2.1]heptanyl]methanol Chemical compound C1CC2C(CO)C(CO)C1C2 YSVZGWAJIHWNQK-UHFFFAOYSA-N 0.000 description 1
- RPJKYODNJDVOOO-UHFFFAOYSA-N [B].F Chemical compound [B].F RPJKYODNJDVOOO-UHFFFAOYSA-N 0.000 description 1
- BHIIGRBMZRSDRI-UHFFFAOYSA-N [chloro(phenoxy)phosphoryl]oxybenzene Chemical compound C=1C=CC=CC=1OP(=O)(Cl)OC1=CC=CC=C1 BHIIGRBMZRSDRI-UHFFFAOYSA-N 0.000 description 1
- PHENPABYBHPABM-UHFFFAOYSA-N acetic acid;octane Chemical compound CC(O)=O.CCCCCCCC PHENPABYBHPABM-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- OWAQXCQNWNJICI-UHFFFAOYSA-N benzene;chloroform Chemical compound ClC(Cl)Cl.C1=CC=CC=C1 OWAQXCQNWNJICI-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical class OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 125000001743 benzylic group Chemical group 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- HUCVOHYBFXVBRW-UHFFFAOYSA-M caesium hydroxide Inorganic materials [OH-].[Cs+] HUCVOHYBFXVBRW-UHFFFAOYSA-M 0.000 description 1
- 229940041011 carbapenems Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 125000005708 carbonyloxy group Chemical group [*:2]OC([*:1])=O 0.000 description 1
- HSJPMRKMPBAUAU-UHFFFAOYSA-N cerium(3+);trinitrate Chemical compound [Ce+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O HSJPMRKMPBAUAU-UHFFFAOYSA-N 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- NEHMKBQYUWJMIP-NJFSPNSNSA-N chloro(114C)methane Chemical compound [14CH3]Cl NEHMKBQYUWJMIP-NJFSPNSNSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000006165 cyclic alkyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 125000001891 dimethoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 235000011167 hydrochloric acid Nutrition 0.000 description 1
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- VCJMYUPGQJHHFU-UHFFFAOYSA-N iron(III) nitrate Inorganic materials [Fe+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O VCJMYUPGQJHHFU-UHFFFAOYSA-N 0.000 description 1
- 229940035429 isobutyl alcohol Drugs 0.000 description 1
- BLQJIBCZHWBKSL-UHFFFAOYSA-L magnesium iodide Chemical compound [Mg+2].[I-].[I-] BLQJIBCZHWBKSL-UHFFFAOYSA-L 0.000 description 1
- 229910001641 magnesium iodide Inorganic materials 0.000 description 1
- CRGZYKWWYNQGEC-UHFFFAOYSA-N magnesium;methanolate Chemical compound [Mg+2].[O-]C.[O-]C CRGZYKWWYNQGEC-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 229940050176 methyl chloride Drugs 0.000 description 1
- 239000011707 mineral Chemical class 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- QCBSZBNUCNSIQH-UHFFFAOYSA-N n-(2-ethylphenyl)methanesulfonamide Chemical compound CCC1=CC=CC=C1NS(C)(=O)=O QCBSZBNUCNSIQH-UHFFFAOYSA-N 0.000 description 1
- DFVWXGKERGYONG-UHFFFAOYSA-N n-(4-methylphenyl)sulfonyl-n-phenylpropanamide Chemical class C=1C=C(C)C=CC=1S(=O)(=O)N(C(=O)CC)C1=CC=CC=C1 DFVWXGKERGYONG-UHFFFAOYSA-N 0.000 description 1
- YJMNLPRMBFMFDL-UHFFFAOYSA-N n-diazo-2-methylbenzenesulfonamide Chemical compound CC1=CC=CC=C1S(=O)(=O)N=[N+]=[N-] YJMNLPRMBFMFDL-UHFFFAOYSA-N 0.000 description 1
- BHQIGUWUNPQBJY-UHFFFAOYSA-N n-diazomethanesulfonamide Chemical compound CS(=O)(=O)N=[N+]=[N-] BHQIGUWUNPQBJY-UHFFFAOYSA-N 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- HDKCVDHYIIKWFM-UHFFFAOYSA-K octanoate;rhodium(3+) Chemical compound [Rh+3].CCCCCCCC([O-])=O.CCCCCCCC([O-])=O.CCCCCCCC([O-])=O HDKCVDHYIIKWFM-UHFFFAOYSA-K 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical class O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 1
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 125000005633 phthalidyl group Chemical group 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229940095574 propionic acid Drugs 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- OLBCVFGFOZPWHH-UHFFFAOYSA-N propofol Chemical compound CC(C)C1=CC=CC(C(C)C)=C1O OLBCVFGFOZPWHH-UHFFFAOYSA-N 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical class O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- HSVFKFNNMLUVEY-UHFFFAOYSA-N sulfuryl diazide Chemical class [N-]=[N+]=NS(=O)(=O)N=[N+]=[N-] HSVFKFNNMLUVEY-UHFFFAOYSA-N 0.000 description 1
- ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical group C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
- NTJBWZHVSJNKAD-UHFFFAOYSA-N triethylazanium;fluoride Chemical compound [F-].CC[NH+](CC)CC NTJBWZHVSJNKAD-UHFFFAOYSA-N 0.000 description 1
- AAPLIUHOKVUFCC-UHFFFAOYSA-N trimethylsilanol Chemical compound C[Si](C)(C)O AAPLIUHOKVUFCC-UHFFFAOYSA-N 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- LSWWNKUULMMMIL-UHFFFAOYSA-J zirconium(iv) bromide Chemical compound Br[Zr](Br)(Br)Br LSWWNKUULMMMIL-UHFFFAOYSA-J 0.000 description 1
- XLMQAUWIRARSJG-UHFFFAOYSA-J zirconium(iv) iodide Chemical compound [Zr+4].[I-].[I-].[I-].[I-] XLMQAUWIRARSJG-UHFFFAOYSA-J 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C07F7/1872—Preparation; Treatments not provided for in C07F7/20
- C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
Definitions
- the present invention relates to a method for producing a azetidinone derivative useful as an intermediate for producing 1-methylcarbapenems having excellent antibacterial activity.
- 1-methylcarbapenems which have excellent antibacterial activity and have high safety / safety, are extremely useful clinically as antibacterial substances for injection.
- it has been developed as an oral administration agent, and is one of the substances that are expected to receive more and more attention in the future.
- R 1 represents a hydrogen atom or a protecting group for a hydroxyl group
- R 6 represents a protecting group for a hydrogen atom or a carboxyl group
- OR 8 represents a leaving group.
- R 1 represents a protecting group for a hydrogen atom or a hydroxyl group
- R 2 represents a protecting group for a hydrogen atom or an amino group
- R 5 represents a hydrogen atom or a nitrogen atom
- R 6 represents a hydrogen atom or a carboxyl group. Represents a protecting group for the group.
- the compound represented by the general formula ( ⁇ ) is described as an intermediate for the production of the general formula (V) in the method disclosed in JP-A-6-321946. That is, it is represented by the following general formula ( ⁇ ′) disclosed in Japanese Patent No. 3220985, Japanese Patent No. 3450193, and Tetrahedron 52, 331-357, 1996, etc., and is commercially available.
- a compound such as a 4-acetoxyzetidinone derivative and a compound of the following formula ( ⁇ ) having an auxiliary group are subjected to a stereoselective carbon-carbon bond forming reaction to give a compound of the following general formula (VI):
- a variety of methods for obtaining compounds have been proposed.
- R 1 represents a protecting group for a hydrogen atom or a hydroxyl group
- R 2 represents a protecting group for a hydrogen atom or an amino group
- R 5 represents a hydrogen atom or a nitrogen atom
- R 6 represents a hydrogen atom or a carboxyl group.
- OR 8 represents a leaving group
- R 9 represents an auxiliary group.
- R 1 represents a hydrogen atom or a protecting group for a hydroxyl group
- R 2 represents a protecting group for a hydrogen atom or an amino group
- R 5 represents a hydrogen atom or a nitrogen atom
- R 6 represents a hydrogen atom.
- OR 8 represents a leaving group
- R 9 represents an auxiliary group
- R 1Q , R U , R 12 , and R 13 are the same or different and are hydrogen or substituted. May represent a group! / Represents a lower alkyl group
- X and Y represent an oxygen atom or a sulfur atom
- the present invention provides 1-methylcarbapenems or 1 ⁇ having excellent antibacterial activity.
- the purpose of the present invention is to provide an industrially superior method for producing a azetidinone derivative that is useful as an intermediate for the production of methyl carbapenems and using an inexpensive auxiliary group without going through complicated steps. ! /
- R 1 represents a hydrogen atom or a hydroxyl protecting group
- R 2 represents a hydrogen atom or a protecting group for an amino group
- R 5 represents a hydrogen atom or a nitrogen atom
- R 6 represents a hydrogen atom or a protecting group for a carboxyl group.
- R 3 represents an aryl group which may have a substituent
- R 4 represents an aryl group that may have a substituent, an aralkyl group that may have a substituent, or an alkyl group that may have a substituent.
- step (b) characterized in that it further comprises diazotization of the compound obtained in step (a) when a compound of formula ( ⁇ ) wherein R 5 is a nitrogen atom is desired It is.
- R 1 and R 2 are as defined above,
- R 7 represents a rualkylcarbonyl-oxy group.
- auxiliary group one N (R 3 ) SO R 4 ) employed in the present invention is required in the conventional method.
- auxiliary groups having a specific cyclic structure and the like can be easily produced at low cost, are industrially suitable, and further effectively function as a leaving group. That is, the auxiliary group employed in the present invention (an N (R 3) SO R 4 ) is a general purpose such Anirin acids and sulfonic acid derivatives
- the two bodies are versatile, with some being used as industrial raw materials, and can be easily manufactured at low cost. Furthermore, the method according to the present invention is industrially excellent because it does not require a complicated process when the carboxyl group is activated after removing the auxiliary group once!
- the above method according to the present invention has the advantageous effect that always high stereoselectivity can be obtained, especially when carried out in the presence of a zirconium reagent.
- the lower alkyl group as a group or a part of the group represents a chain, branched, or cyclic alkyl group having preferably 1 to 6 carbon atoms.
- Specific examples thereof include a methyl group, Ethyl group, n-propyl group, i-propyl group, cyclopropyl, n-butyl group, i-butanol group, sec-butyl group, t-butyl group, cyclobutyl group, n-pentyl group, cyclopentyl group, n-hexyl group, cyclohexyl group Groups and the like.
- the aryl group is an aromatic cyclic compound, and examples thereof include a phenyl group, a naphthyl group, and a pyridyl group.
- the aralkyl group represents an arylalkyl group, and in the group, the alkyl group portion is preferably
- the lower alkyl group is represented, and the aryl group represents the aryl group. Therefore, specific examples thereof include benzyl group, phenethyl group, 3-phenylpropyl group, naphthylmethyl group, pyridylmethyl group and the like.
- halogen atom examples include a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom.
- a compound of the general formula (I) is reacted with imidazole to give an imidazolide compound, and then reacted with a malonic ester to give a compound of formula ( ⁇ ) in which R 5 is a hydrogen atom. obtain.
- R 1 is a hydrogen atom or a hydroxyl protecting group
- R 2 is a protecting group of hydrogen atom or Amino group
- R 6 is hydrogen atom or a protecting group of a carboxyl group
- the protective groups for the hydroxyl group, amino group, and carboxyl group respectively, commonly used protective groups described in PROT ECTVE GROUPS in ORGANIC SYNTHESIS THIRD EDITION (WILEY) can be used.
- Specific examples of the hydroxyl protecting group include silyl protecting groups such as trimethylsilyl group, triethylsilyl group, and t-butyldimethylsilyl group.
- the amino protecting group includes trimethylsilyl group, triethylsilyl group, and t-butyl group.
- examples include silyl protecting groups such as dimethylsilyl group, benzyl protecting groups such as benzyl group, noramethoxybenzyl group, paranitrobenzyl group, benzhydryl group, etc.
- Benzylic protecting groups such as paranitrobenzyl group, benzhydryl group, bivalloyloxymethinole group, 1- (cyclohexinole xycanoleponinole xy) ethinole group, acetoxymethinole group, 1- (isopropyloxy group) Carbonyloxy) ethyl group, 1- (ethoxycal Benzyloxy) ethyl, cyclohexyloxycarbonyloxymethyl, 1- (cyclohexyloxycarbonyloxy) -2-methylpropane-1-yl, isopropyloxycarbonyloxymethyl, phthalidyl And ester groups that can be hydrolyzed in vivo, such as groups.
- R 2 is a hydrogen atom, a trimethylsilyl group, a triethylsilyl group, a t-butyldimethylsilyl group, a benzyl group, a nonamethoxybenzyl group, or a paranitro group.
- R 6 includes a benzyl group, a paramethoxybenzyl group, a parabitrobenzyl group, a benzhydryl group, a bivalyloxymethyl group, 1 -(Cyclohexylcarbonyloxy) ethyl group, acetoxymethyl group, 1- (isopropyloxycarbonyloxy) ethyl group, cyclohexyloxycarbonyloxymethyl group, ester group that can be hydrolyzed in the body, etc. More preferred examples include a paranitrobenzyl group and a paramethoxybenzyl group.
- R 3 may have a substituent! /,
- An aryl group and preferred examples of the aryl group include aromatic cyclic compounds such as a phenyl group, a naphthyl group, and a pyridyl group.
- Substituents include halogen atoms such as fluorine atom, chlorine atom, bromine atom and iodine atom, methyl group, trifunoleolomethinole group, trichloromethinole group, ethyl group, n-propyl group and i-propyl group.
- N butyl group i butyl group, sec butyl group, t butyl group, lower alkyl group, methoxy group, ethoxy group and other lower alkyl group, amino group, monoalkyl which may be substituted with halogen atoms
- Examples include amino groups (for example, monomethylamino group and monoethylamino group), and dialkylamino groups (for example, dimethylamino group, jetylamino group), amino groups such as cyano group and nitro group.
- the bonding position is selected from the 2,3, 2,4, 2,5, 2,6, 3, 4 or 3,5 position, and beyond
- a position selected from any conceivable position may be substituted. If the substituent is adjacent disubstitution, the ends of both substituents may be integrated. In that case, an aliphatic ring to which propylene, butylene, or the like is bonded, methylenedioxy, ethylenedioxy, or the like is bonded. The thing which formed the cyclic ether compound is mentioned.
- preferable R 3 includes phenyl group, bromophenyl group, fluorophenyl group, chlorophenyl group, methylphenyl group, dimethylphenyl group, ethenylphenyl group, i-propylphenyl group. , T-butylphenyl group, methyl-methoxyphenyl group, chloro-methylphenyl group, trifluoromethylphenyl group, methoxyphenyl group, cyanophenyl group, nitrophenyl group, methoxycarbonylphenyl group, methylenedioxyphenyl group, ethylenedioxy group A phenyl group etc. are mentioned, The position of the substituent on a phenyl group is as above-mentioned, respectively.
- R 4 is an aryl group, aralkyl group, or alkyl group which may have a substituent, and examples of the substituent include the same substituents as those described above for R 3 .
- An alkyl group is a lower alkyl group that may be substituted with a halogen atom or the like.
- a methyl group, a trifunoleolomethinole group, a trichloromethinole group, an ethyl group, an n-propyl group, an i-propyl group Examples include n-butyl group, i-butyl group, sec-butyl group, and t-butyl group.
- the aryl group which may have a substituent is a force having the same meaning as described above, for example, a phenyl group, a methylphenyl group, a naphthyl group, a pyridyl group and the like.
- the aralkyl group has the same meaning as described above, and examples thereof include a benzyl group, a phenethyl group, a 3-phenylpropyl group, a naphthylmethyl group, and a pyridylmethyl group.
- Preferred R 4 phenyl group, main Chirufueniru group, a benzyl group, or the like methyl.
- R 5 is a hydrogen atom or a nitrogen atom.
- the malonic acid ester to be reacted after reacting the compound of formula (I) with imidazole is preferably a malonic acid monoester, and the ester portion of the malonic acid monoester corresponds to. Accordingly, this ester moiety is preferably selected from those listed for R 6 , and specific examples of malonic acid monoesters include malonic acid monobenzil ester, malonic acid mono-p-nitrobenzinoreestenole, malonic acid monoester. Examples thereof include pivaloino reoxymethino ester, and preferably, malonic acid mono-p nitrobenzil ester and the like.
- Step (a) that is, the reaction for obtaining a compound in which R 5 is a hydrogen atom among the compounds represented by the general formula ( ⁇ ), is carried out under an inert gas atmosphere such as nitrogen or argon as the first step.
- an inert gas atmosphere such as nitrogen or argon
- imidazole is allowed to act in the presence or absence of a base catalyst.
- any solvent that is not involved in the reaction can be used as long as it is an inert solvent.
- Hydrocarbon solvents such as methylene chloride, chlorine solvents such as 1,2-dichloroethane and chloroform, aromatic hydrocarbon solvents such as benzene, chloroform benzene, toluene and xylene, jetyl ether, diisopropyl ether, dimethoxy Organic solvents such as ether solvents such as ethane, tetrahydrofuran, 1,4 dioxane and cyclopentyl methyl ether, acetate solvents such as ethyl acetate and butyl acetate, or aprotic polar solvents such as acetonitrile , Can be used by appropriately mixing a plurality of types, preferably methylene chloride, ethyl acetate, Tonitoriru and the like.
- Base catalysts include pyridine, 4 dimethylaminopyridine, 2 picoline, 3 picoline, 4 picoline, aniline, N methylaniline, N, N dimethylaniline, 2,3-tidine, 2,4,6-collidine, 1, Organic bases such as 4-diazabicyclo [2.2.2] octane, 1,5 diazabicyclo [4 ⁇ 3.0] nona 5-ene, 1,8 diazabicyclo [5.4.0] Examples include 4-dimethylaminopyridine.
- the use ratio (weight / volume ratio) of the general formula (I) and the solvent is usually from 1: 5 to 100, and preferably from 1:10 to 50.
- the use ratio (molar ratio) of the general formula (I) to the base catalyst is usually from 1: 0.0 to 0.5, preferably 1: 0 ⁇ 05-0.2.
- the use ratio (molar ratio) of the general formula (I) and imidazole is usually 1: 1 to 10 and preferably 1 :;! To 5.
- the reaction temperature is generally ⁇ 30 to; 100 ° C., preferably 30 to 60 ° C.
- the reaction usually proceeds in 0.5 to 48 hours, preferably 2 to 24 hours, and 3 to 6 hours is preferable.
- the imidazolide compound obtained by this reaction can be isolated by a general separation and purification method. Since the compound is unstable, it is usually convenient to directly apply to the next step. .
- the reaction mixture containing the imidazolide compound thus obtained is usually subsequently subjected to the next step, but can be appropriately cooled and stored.
- the cooling temperature for storage is ⁇ 80 to 0 ° C., preferably ⁇ 30 to ⁇ 10 ° C. Also, The storage period is from several hours to two days, preferably within 24 hours.
- step (a) that is, the reaction to obtain a compound in which R 5 is a hydrogen atom among the compounds represented by the general formula ( ⁇ )
- imidazole acts on the compound of the formula (I) as the second step. And then add malonic acid ester.
- the reaction is carried out in the presence of a magnesium compound.
- the magnesium compound include magnesium chloride, magnesium bromide, magnesium bromide ether complex, magnesium iodide, magnesium methoxide. , Magnesium ethoxide and the like are used, and preferably magnesium chloride is used.
- the reaction is carried out in the presence of a base.
- the base include trimethylamine, triethylamine, tributylamine, trioctylamine, diisopropyl pyrethylamine, ⁇ methyl Pyrrolidine, ⁇ -methylpiperidine, ⁇ methylmorpholine, pyridine, 4 dimethylaminopyridine, 2 picoline, 3 picoline, 4-picoline, aniline, ⁇ methylaniline, ⁇ , ⁇ -dimethylaniline, 2,3 lutidine, 2, 4 lutidine, 2,5 lutidine, 2,6 lutidine, 3,4-lutidine, 3,5-lutidine, 2,4,6-collidine, 1,4-diazabicyclo [2.2.2] octane, 1,5 diazabicyclo [ 4.3.0] —Nonah 5 and 1,8 diazabicyclo [5.4.0] —Undecar 7—en,
- reaction mixture containing an imidazolide compound obtained separately is added to a mixture obtained by reacting a magnesium compound, a base group, and a malonic ester in an organic solvent.
- a magnesium compound, a base and malonic acid monoester is usually 1: 0 ⁇ 5 to 3, preferably 1: 0 ⁇ 7 to!
- the use ratio (molar ratio) of the general formula (I) to the base is usually 1: 1 to 6, preferably 1: 1.5 to 3.
- the use ratio (molar ratio) of the general formula (I) to the malonic acid monoester is usually 1:;!-3, and preferably 1:;!-2.
- the temperature at which the magnesium compound, base and malonic acid monoester are added is usually from -80 to 0 ° C, preferably from -30 to -10 ° C.
- the reaction temperature after adding all necessary reagents is -30 to 100 ° C, preferably 30 to 6 0 ° C.
- the reaction usually proceeds in 0.5 to 20 hours, preferably 1 to 5 hours.
- reaction mixture is worked up according to a conventional method, and is isolated by a general separation and purification method to obtain the general formula (II) (wherein R 5 is a hydrogen atom). I can do it.
- step (a) If a compound of formula (II) in which R 5 is a nitrogen atom is desired, the compound obtained in step (a) is further diazotized.
- the general formula ( ⁇ ) (wherein R 5 is a hydrogen atom) obtained in the step (a) is diazotized as it is without isolating the general formula ( ⁇ ) ( In the formula, R 5 is a nitrogen atom).
- the organic solvent used at this time is an ability to use an inert solvent that does not participate in the aforementioned reaction.
- a hydrocarbon solvent, a chlorinated solvent, an aromatic hydrocarbon which are convenient for use in the post-treatment of the reaction.
- System solvents and acetic acid-sterol solvents are used, and ⁇ -heptane, methylene chloride, toluene, ethyl acetate, etc. are preferably used.
- An azide compound and a base are used for diazotization.
- the azide compound sulfonyl azides such as methanesulfonyl azide, toluenesulfonyl azide, ⁇ -carboxybenzenesulfonyl azide and dodecylbenzenesulfonyl azide are used, and preferably dodecylbenzenesulfonyl azide and the like.
- Bases include trimethylamine, triethylamine, tributylamine, trioctylamine, diisopropylethylamine, ⁇ -methylpyrrolidine, ⁇ -methylpiperidine, ⁇ -methinole monoreforin, pyridine, 4-dimethylaminopyridine, 2 —Picoline, 3-Picoline, 4-Picoline, Aniline, ⁇ -Methylaniline, ⁇ , ⁇ -Dimethylaniline, 2,3-Lutidine, 2,4-Lutidine, 2,5-Lutidine, 2,6-Lutidine, 3,4-lutidine, 3,5-lutidine, 2,4,6-collidine, 1,4-diazabicyclo [2.2.2] octane, 1,5-diazabicyclo [4.3.0] —noner-5-ene, 1, 8-Zazabicyclo [5.4.0] -undecar 7-en and the like are used, and preferred is triethyl
- the use ratio (molar ratio) of the general formula (I) to the azide compound is usually from 1: 0.7 to 2, preferably;!:;! To 1 ⁇ 5.
- the use ratio (molar ratio) of the general formula (I) to the base is usually 1: 0 ⁇ ;! ⁇ 1, preferably 1: 0.2 ⁇ 0.5.
- the reaction normally proceeds at -20-50 ° C, preferably Is 0-50 ° C.
- the reaction time is usually 0.5 to 48 hours, preferably; !! to 24 hours, 3 to 15 hours is preferred.
- reaction mixture thus obtained is subjected to work-up according to a general method commonly used by those skilled in the art, and is further isolated by a general separation and purification method to give a general formula ( ⁇ ) (wherein R 5 is a nitrogen atom).
- a general separation and purification method to give a general formula ( ⁇ ) (wherein R 5 is a nitrogen atom).
- a sodium hydrogen carbonate aqueous solution, a potassium hydrogen carbonate aqueous solution, a sodium carbonate aqueous solution, a potassium carbonate aqueous solution, a sodium hydroxide aqueous solution, a potassium carbonate aqueous solution, an aqueous ammonia, or the like is used, preferably a sodium hydroxide aqueous solution. It is.
- the concentration of the dilute alkaline aqueous solution is usually from 0.;! To 3 mol / L, preferably from 0.5 to Imol / L.
- Separation and purification is a force that can be used by an ordinary general method, preferably a method of forming a precipitate, and can be performed by appropriately concentrating the post-treatment solution.
- an organic solvent such as n-heptane is appropriately added and further aged, and the resulting precipitate is collected by filtration to give a general formula (1) useful as a production intermediate for 1-methylcarbapenems ( II)
- a azetidinone derivative represented by the formula (wherein R 5 is a nitrogen atom) can be obtained.
- R 1 of the obtained general formula (II) When a protective group is present in R 1 of the obtained general formula (II), it is removed by a commonly used deprotection method described in PROTECTVE GROUPS in ORGANIC SYNTHESIS THIRD EDITION (WILEY). As a protection, it can be a azetidinone derivative represented by the general formula ( ⁇ ) (wherein R 1 is a hydrogen atom and R 5 is a hydrogen atom or a nitrogen atom).
- R 1 is a protecting group of hydroxyl group
- isolated and purified general formula ([pi) can also be used, after the reaction, including the general formula ([pi)
- the treatment solution can be used as it is.
- the organic solvent used is a solvent that does not participate in the reaction, for example, a hydrocarbon solvent such as n-pentane, n-hexane, cyclohexane, n-heptane, or a mixture of isomers thereof.
- Chlorinated solvents such as methylene chloride, 1,2-dichloroethane, chloroform, aromatic hydrocarbon solvents such as benzene, black benzene, toluene, xylene, jetyl ether, diisopropyl ether, dimethoxyethane , Tetrahydrofuran, 1,4 dioxane, ether solvents such as cyclopentyl methyl ether, acetate solvents such as ethyl acetate, butyl acetate, aprotic polar solvents such as acetonitrile, N, N-dimethylformamide, dimethyl sulfoxide, or methanol , Ethanol, 1-prono, 2-prono, 1-butanol, 2-butanol, organic solvents such as isobutyl alcohol, tert-butyl alcohol, etc.
- aromatic hydrocarbon solvents such as benzene, black benzene, toluene,
- methyl chloride for example, methyl chloride, acetonitrile, tetrahydrofuran, methanol, and more preferred is a mixture of methylene chloride and methanol as appropriate.
- the mixing ratio (volume ratio) of methyl chloride and methanol is usually 1: 0 to 0: 1, preferably 1:;! To 4.
- the desilylating agents include formic acid, acetic acid, trifluoroacetic acid, propionic acid, methanesulfonic acid, benzenesulfonic acid, ptoluenesulfonic acid, camphorsulfonic acid and other organic acids, hydrochloric acid, Mineral acids such as hydrobromic acid, sulfuric acid, nitric acid, phosphoric acid, boron trifluoride, boron trifluoride jetyl ether complex, titanium tetrachloride, zirconium tetrachloride, aluminum chloride, ferric chloride, ferric nitrate Lewis acids such as copper and cerium (III) nitrate, alkali hydroxides such as lithium hydroxide, sodium hydroxide, potassium hydroxide and cesium hydroxide, hydrogen fluoride, ammonium fluoride, triethylamine hydrofluoride complex, fluoride Hydrogen pyridine complex, te
- the use ratio (weight / volume ratio) of the general formula ( ⁇ ) (wherein R 1 is a hydroxyl-protecting group) and the solvent is usually 1: 2 to 50, preferably 1 : 5-20.
- the amount of desilylating agent used is in the range of stoichiometric to large excess.
- the reaction temperature is usually 20-60 ° C, preferably 0-40 ° C.
- the reaction time is usually 0.5 to 24 hours, preferably 1 to 17 hours.
- the compound of formula (I) used in the production of the compound of formula (II) according to the present invention is known, for example, the above-mentioned Japanese Patent No. 3220985, Japanese Patent No. 3450193, and Tetrahedron 52 331- 357 can be obtained by the method described in 1996.
- the compound of formula (I) is preferably prepared according to the following scheme, and this method constitutes another embodiment of the present invention.
- R 1 represents a hydrogen atom or a protecting group of a hydroxyl group
- R 2 represents a hydrogen atom or a protective group for an amino group
- R 3 represents an Ariru group which may have a substituent
- R 4 Represents an aryl group, aralkyl group or alkyl group which may have a substituent
- R 7 represents an alkyl group or a alkoxyloxy group.
- the compound represented by the general formula (IV) can be carried out by a known method. For example, an aniline compound (R 3 NH) and a sulfonic acid derivative (R 4 SO X) are reacted to form a sulfonanilide compound (HN).
- R 1 and R 2 are a hydrogen atom or a protecting group for a hydroxyl group and an amino group, respectively, and the hydroxyl group and the protecting group for an amino group are described in the above-mentioned books and the like.
- the protecting groups for hydroxyl and amino groups are as defined above, and preferred R 1 is a hydrogen atom or a trimethylsilyl group, a triethylsilyl group, t-butyldimethyl. Examples thereof include a silyl group, and more preferably a t-butyldimethylsilyl group.
- Preferred R 2 is hydrogen atom, trimethylsilyl group, Toryechirushiriru group, t Buchinore dimethylsilyl group, a benzyl group, p-methoxybenzyl group, para nitro downy Njiru group, such as Ben Zuhidoriru group and the like, more preferably, hydrogen Atoms, paranitrobenzyl groups, etc.
- R 3 has the same meaning as described above, and R 3 is an aryl group which may have a substituent.
- the aryl group include aromatic cyclic compounds such as a phenyl group, a naphthyl group, and a pyridyl group.
- substituents examples include a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom, a methinore group, a trifunoleolomethinole group, a trichloromethinole group, an ethyl group, an n-propyl group, an i— Propinole group, n-butyl group, i-butyl group, sec-butyl group, t-butyl group, lower alkyl group which may be substituted with halogen atom, etc., methoxy group, lower alkyloxy group such as ethoxy group, amino group Monoalkylamino groups (for example, monomethylamino group, monoethylamino group, etc.), dialkylamino groups (for example, dimethylamino group, jetamino group, etc.).
- a halogen atom such as a fluorine
- Is) amino group such as, like Shiano and nitro.
- One or more substituents may be the same or different when there are multiple substituents, and the substitution position is selected from the 2-position, 3-position or 4-position of the bonding position when there is one substituent.
- substitution positions selected from the 2,3, 2,4, 2,5, 2,6, 3,4, or 3,5 positions of the bond position or more When there is a group, a position selected from any conceivable position may be substituted. If the substituent is adjacent disubstitution, the ends of both substituents may be integrated. In that case, an aliphatic ring to which propylene, butylene, or the like is bonded, methylenedioxy, ethylenedioxy, or the like is bonded.
- R 4 is an aryl group, aralkyl group or alkyl group which may have a substituent, and the substituent has the same meaning as the substituent described above for R 3 .
- An alkyl group is a lower alkyl group which may be substituted with a halogen atom or the like, for example, methyl group, trifluoromethylol group, trichloromethyl group, ethyl group, n propyl group, i propyl group, n butynole group, i Examples thereof include a butyl group, a sec butyl group, and a t butyl group.
- the aryl group which may have a substituent includes a force S as defined above, for example, a phenyl group, a methylphenyl group, a naphthyl group, a pyridyl group and the like.
- the aralkyl group has the same meaning as described above, and examples thereof include a benzyl group, a phenethyl group, a 3-phenylpropyl group, a naphthylmethyl group, and a pyridylmethyl group.
- Preferable R 4 includes a phenyl group, a methylphenyl group, a benzyl group, or a methyl group.
- R 7 represents an alkylcarbonyl group, preferably an acetyloxy group.
- the reaction is preferably carried out in an organic solvent under an inert gas atmosphere such as nitrogen or argon.
- an organic solvent any inert solvent that does not participate in the reaction can be used.
- hydrocarbon solvents such as n-pentane, n-hexane, cyclohexane, n-heptane, or mixtures of these different substances.
- Solvents such as methylene chloride, 1,2 dichloroethane, chloroform, aromatic hydrocarbon solvents such as benzene, chlorobenzene, toluene, xylene, jetyl ether, diisopropyl ether, dimethoxyethane,
- a single organic solvent such as an ether solvent such as tetrahydrofuran, 1,4 dioxane, cyclopentyl methyl ether, or the like can be used by appropriately mixing a plurality of types, preferably methylene chloride.
- Examples of the dinoleconium compound include dinoleconium tetrafluoride, dinoleconium tetrachloride, zirconium tetrabromide, zirconium tetraiodide, zirconium tetra-i-propoxide, and preferably zirconium tetrachloride.
- Examples of the base include dimethylamine, trimethylamine, jetylamine, triethylamine, dibutylamine, tributylamine, trioctylamine, diisopropylethylamine, bistrimethinoresinoleamine, pyrrolidine, N-methylpyrrolidine, Piperidine, N-methylbiperidine, morpholine, N-methylmorpholine, tetramethylethylenediamine, pyridine, 4-dimethylaminopyridine, 2-picoline, 3-picoline, 4-picoline, aniline, N-methylaniline, N, N-dimethyla Nilin, 2,3 lutidine, 2,4 lutidine, 2,5 lutidine, 2,6-norethidine, 3,4-lutidine, 3,5-lutidine, 2,4,6-collidine, 1,4-diazabicyclo [2 ⁇ 2-2] Octane, 1,5 diazabicyclo [4.3.0] Noner 5, 1,8 diaza
- the order in which the reagents are added is not particularly limited, but is preferably added in the order of the zirconium compound, the base and then the general formula (III) to the solution of the organic solvent of the general formula (IV).
- the use ratio (weight / volume ratio) of the general formula (III) and the solvent is usually from 1:10 to 100; preferably from 1:10 to 30.
- the use ratio (molar ratio) of the general formula (III) to the general formula (IV) is usually!:;! ⁇ 3, preferably 1: 1: 2 ⁇ 2.
- the use ratio (molar ratio) of the zirconium compound is usually 1 ::! To 3, preferably 1: 1.2-2.
- the use ratio (molar ratio) of the base catalyst is usually 1: 1 to 3, preferably 1: 1.2-2.
- an aprotic polar solvent such as acetonitrile, ⁇ , ⁇ dimethylformamide, dimethyl sulfoxide, etc. be added as appropriate, thereby improving the reaction yield and / or stereoselectivity.
- the yield can be further improved by adding a trace amount of a protic solvent such as water and methanol.
- the reaction temperature is usually from 30 to 50 ° C, preferably from 15 to 30 ° C.
- the reaction time is usually 0.5 to 24 hours, preferably 1 to 5 hours.
- reaction mixture is subjected to post-treatment according to a conventional method, and is isolated by a general separation and purification method, for example, purification by silica gel column chromatography or a method of forming a precipitate. ) Can be obtained.
- a general separation and purification method for example, purification by silica gel column chromatography or a method of forming a precipitate.
- TBS t butyldimethylsilyl group
- DIPEA Diisopropylethylamine
- N propionyl N-phenyl p-toluenesulfonamide derivatives can be produced in the same manner as in Production Example 1.
- N-propionyl N— (2-trifluoromethylphenol) p-toluenesulfonamide (Compound 3) 22.29 g (60.0 mmol) in methylene chloride (345 mU solution in an ice bath) After cooling at room temperature, 2098 g (90.0 mmol) of zirconium chloride was added and stirred at the same temperature for 30 minutes, and then 16.5 mL (94.7 mmol) of DIPEA was added and stirred at the same temperature for 30 minutes, and then (3R, 4R) — 4 [(R) 1 (tert-butyldimethylsilyloxy) ethyl] 2 azetidinone 17.25 g (60.0 mmol) was added, and the reaction was allowed to proceed for 1 hour while removing the ice bath and raising the temperature to room temperature.
- N propionyl N— (2-trifluoromethylphenol) p toluenesulfonamide compound 3
- 26.75 g (72.0 mmol) of methylene chloride (345 mU solution was cooled in an ice bath).
- Zirconium chloride 21.67 g, 93.0 mmol was added and stirred at the same temperature for 30 minutes, then DIPEA 16.2 mL (93.0 mmol) was added, and the mixture was stirred at the same temperature for 30 minutes.
- Example 1 1 N [(2R) 2- ⁇ (3S, 4R) 3— [(1R) — 1 (tert butyldimethylsilyloxy) ethyl] — 2 oxoazetidine 4 inole ⁇ propioninole N (3,5 dimethylphenolinole)- p Production of toluenesulfonamide
- N-propionyl, N— (2-ethylphenyl) methanesulfonamide 1.35 g (5.29 mmol) was used in the same manner as in Example 2 to obtain 0.45 g (yield 21.2%) of the title compound as a white powder.
- N [(2R) — 2— ⁇ (3S, 4R) — 3— [(1R) — 1 (tert-butyldimethyldimethyloxy) ethinole 2 oxazotidine 4 inole ⁇ propioninore N mono (2 trifluoromethylphenyl) p toluenesulfonamide (compound 4) 600 mg (1.00 mmol) of acetonitrile (9 mU solution with imidazole 200 mg (3.00 mmol) and DMAP 1 2.5 mg (0.102 mmol) ) And allowed to react for 16 hours at 60 ° C.
- the title compound (Compound 5) is a known substance, and the retention time and 1 H wake R spectrum of the existing product and the HPLC coincided.
- N [(2R) — 2— ⁇ (3S, 4R) — 3— [(1R) — 1 (tert-butyldimethyldimethyloxy) ethinole 2 oxazotidine 4 inole ⁇ propioninore N- (2 trifluoromethylphenyl) p-toluenesulfonamide (compound 4) 3.0 g (5.00 mmol) of acetonitrile (1.0 m imidazole (15.0 mmol) and DMAP 60 mg (0.491 mmol) added to 9 mU solution) The mixture was allowed to react for 19 hours at 60 ° C.
- the reaction mixture was cooled in an ice bath and 0.48 g (5.01 mmol) of magnesium chloride, 1.4 mL (10.0 mmol) of TEA and 2.04 g of malonic acid mono-p-nitrobenzyl ester ( 8.53 mmol) was added in order, and the mixture was heated to 50 ° C. and reacted for 2 hours, the reaction mixture was concentrated under reduced pressure, and the concentrated solution was diluted with methylene chloride (48 mL), and 1M hydrochloric acid, water, 5% aqueous sodium bicarbonate and The solution was washed successively with 10% brine, and the resulting solution containing Compound 5 was added to dodecinolebenzenesulfonyl azimuth.
- N [(2R) — 2— ⁇ (3S, 4R) — 3— [(1R) — 1 (tert-butyldimethylsilyloxy) ethinole] 2 oxazotidine 4 inole ⁇ propionate
- N phenyl p-toluenesulfonamide
- 5.32 g (10.0 mmol) of acetonitrile Into an 80 mU solution, 2.05 g (30.1 mmol) of imidazole and 0.12 g (1.00 mmol) of DMAP were added and allowed to react for 6 hours at 60 ° C. The reaction mixture was cooled to 15 ° C.
- the title compound (Compound 8) is a known substance, and the retention time and 1 H-wake R spectrum of the existing product and the HPLC coincided.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008529869A JPWO2008020597A1 (ja) | 2006-08-15 | 2007-08-15 | 1−メチルカルバペネム類製造中間体の製造方法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006221475 | 2006-08-15 | ||
JP2006-221475 | 2006-08-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008020597A1 true WO2008020597A1 (fr) | 2008-02-21 |
Family
ID=39082121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2007/065896 WO2008020597A1 (fr) | 2006-08-15 | 2007-08-15 | Procédé de production d'un intermédiaire pour la production de 1-méthylcarbapenem |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPWO2008020597A1 (fr) |
KR (1) | KR20090040333A (fr) |
CN (1) | CN101500992A (fr) |
WO (1) | WO2008020597A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101891666B (zh) * | 2010-07-20 | 2012-09-26 | 深圳市海滨制药有限公司 | 一种β甲基碳青霉烯类抗生素中间体的制备方法 |
CN101906115B (zh) * | 2010-08-13 | 2012-12-05 | 浙江海翔药业股份有限公司 | 一种β-甲基碳青霉烯抗生素中间体的制备方法 |
CN102690282A (zh) * | 2011-07-07 | 2012-09-26 | 深圳市海滨制药有限公司 | 晶体形式的1β甲基碳青霉烯类抗生素中间体及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63284176A (ja) * | 1987-05-15 | 1988-11-21 | Nippon Redarii Kk | (1r,5r,6s)−6−〔(1r)−1−ヒドロキシエチル〕−1−メチルカルバペネム−3−カルボン酸誘導体の高立体選択的製造方法 |
JPH0543575A (ja) * | 1991-12-21 | 1993-02-23 | Mercian Corp | アゾール誘導体 |
WO1993013064A1 (fr) * | 1991-12-26 | 1993-07-08 | Nippon Soda Co., Ltd. | Procede de production d'un derive d'azetidinone substitue en position 4 |
JPH0782249A (ja) * | 1993-06-30 | 1995-03-28 | Nippon Soda Co Ltd | 4−置換アゼチジノン誘導体の製造法 |
JPH1087657A (ja) * | 1996-09-06 | 1998-04-07 | Nippon Soda Co Ltd | アゼチジノン誘導体の製造法 |
-
2007
- 2007-08-15 JP JP2008529869A patent/JPWO2008020597A1/ja active Pending
- 2007-08-15 KR KR1020097003035A patent/KR20090040333A/ko not_active Application Discontinuation
- 2007-08-15 WO PCT/JP2007/065896 patent/WO2008020597A1/fr active Application Filing
- 2007-08-15 CN CNA2007800302669A patent/CN101500992A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63284176A (ja) * | 1987-05-15 | 1988-11-21 | Nippon Redarii Kk | (1r,5r,6s)−6−〔(1r)−1−ヒドロキシエチル〕−1−メチルカルバペネム−3−カルボン酸誘導体の高立体選択的製造方法 |
JPH0543575A (ja) * | 1991-12-21 | 1993-02-23 | Mercian Corp | アゾール誘導体 |
WO1993013064A1 (fr) * | 1991-12-26 | 1993-07-08 | Nippon Soda Co., Ltd. | Procede de production d'un derive d'azetidinone substitue en position 4 |
JPH0782249A (ja) * | 1993-06-30 | 1995-03-28 | Nippon Soda Co Ltd | 4−置換アゼチジノン誘導体の製造法 |
JPH1087657A (ja) * | 1996-09-06 | 1998-04-07 | Nippon Soda Co Ltd | アゼチジノン誘導体の製造法 |
Also Published As
Publication number | Publication date |
---|---|
JPWO2008020597A1 (ja) | 2010-01-07 |
KR20090040333A (ko) | 2009-04-23 |
CN101500992A (zh) | 2009-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5202635B2 (ja) | インテグラーゼ阻害剤の調製のためのプロセスおよび中間体 | |
WO2021175296A1 (fr) | Intermédiaire de remdésivir et son procédé de préparation | |
CN102630226A (zh) | 恩替卡韦的合成方法及其中间体化合物 | |
EP0167154B1 (fr) | Procédé pour la préparation de dérivés de 4-acétoxy-3-hydroxyéthylazetizin-2-one | |
WO2008020597A1 (fr) | Procédé de production d'un intermédiaire pour la production de 1-méthylcarbapenem | |
CN113045416B (zh) | 一种(r)-3-羟基丁酰-(r)-3-羟基丁酯的制备方法 | |
JP5180289B2 (ja) | キラル補助剤を用いた4−bmaの立体選択的製造方法 | |
WO2015070394A1 (fr) | Procédé de préparation d'un intermédiaire d'antibiotiques pénem | |
JPH066570B2 (ja) | 4−アセトキシ−3−ヒドロキシエチルアゼチジン−2−オン誘導体の製造法 | |
CN102351860B (zh) | 一种帕尼培南及其中间体的合成方法 | |
JP3467265B2 (ja) | アゼチジノン化合物の結晶 | |
EP3686208B1 (fr) | Intermédiaires pour la préparation de composés halichondrine et leur procédé de préparation | |
CN109232322B (zh) | 一种井冈霉醇胺关键中间体的合成方法 | |
CN101845072A (zh) | 2’-脱氧-2’,2’-二氟-3’,5’-双(取代苯甲酸酯基)胞嘧啶及其精制方法 | |
JP4572433B2 (ja) | N−アセチルホモピペラジン類の製造法 | |
JP3184345B2 (ja) | 5−クロロオキシインドールの製造方法 | |
JP3213734B2 (ja) | 新規β−ラクタム化合物 | |
JPH0931075A (ja) | カルバペネム中間体の製造方法 | |
JP3758707B2 (ja) | (−)−トランス−クマウシンの製法および新規中間体 | |
JP4267107B2 (ja) | ピリジン誘導体およびその製造方法 | |
JP5143556B2 (ja) | 糖テンプレートを用いたカルバペネム合成中間体の新規合成法 | |
JPH0931054A (ja) | アゼチジノン化合物及びその製造方法 | |
JP2604794B2 (ja) | 4−アセトキシ−3−ヒドロキシエチルアゼチジン−2−オンの製造法 | |
KR100283608B1 (ko) | 1-베타메틸-2-포르밀카바페넴유도체의제조방법 | |
CN117659032A (zh) | 海鞘素类衍生物的中间体及其的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780030266.9 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07805928 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008529869 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1074/DELNP/2009 Country of ref document: IN Ref document number: 1020097003035 Country of ref document: KR |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07805928 Country of ref document: EP Kind code of ref document: A1 |